Literature DB >> 17613551

Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.

Auli Karhu1, Lauri A Aaltonen.   

Abstract

Pituitary tumors are common intracranial neoplasms. Although histologically benign, pituitary tumors can cause significant morbidity due to their critical location, expanding size and oversecretion of pituitary hormone expression. The majority of pituitary tumors are sporadic, but some arise as a component of hereditary syndromes. Our understanding of these genetic conditions has expanded rapidly due to the identification of new predisposing genes. Four specific genes have been identified that predispose to hereditary pituitary neoplasia; MEN1, PRKAR1A, CDKN1B and AIP, of which CDKN1B and AIP have been identified only recently. These genes underlie multiple endocrine neoplasia type 1, Carney complex, MEN1-like phenotype and pituitary adenoma predisposition, respectively. The present study review the current state of knowledge regarding the genes associated to inherited pituitary neoplasia, with a particular focus on the novel pituitary adenoma predisposing genes, CDKN1B and AIP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613551     DOI: 10.1093/hmg/ddm036

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma.

Authors:  Karolin H Nord; Linda Magnusson; Margareth Isaksson; Jenny Nilsson; Henrik Lilljebjörn; Henryk A Domanski; Lars-Gunnar Kindblom; Nils Mandahl; Fredrik Mertens
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred.

Authors:  Xiaohua Li; Jing Su; Li Zhao; Jingcheng Wu; Xiaoying Ding; Fang Fang; Yijie Wu; Haiyan Sun; Yongde Peng
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

3.  mTOR is frequently active in GH-secreting pituitary adenomas without influencing their morphopathological features.

Authors:  Emir Ahmed Sajjad; Grzegorz Zieliński; Maria Maksymowicz; Łukasz Hutnik; Tomasz Bednarczuk; Paweł Włodarski
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

4.  Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  US Endocrinol       Date:  2009-02-01

Review 5.  Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  Expert Rev Neurother       Date:  2008-04       Impact factor: 4.618

6.  The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.

Authors:  Elina Heliövaara; Anniina Raitila; Virpi Launonen; Anders Paetau; Johanna Arola; Heli Lehtonen; Timo Sane; Robert J Weil; Outi Vierimaa; Pasi Salmela; Karoliina Tuppurainen; Markus Mäkinen; Lauri A Aaltonen; Auli Karhu
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

7.  Facial metrics in children with corticotrophin-producing pituitary adenomas suggest abnormalities in midface development.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2009-01       Impact factor: 1.634

Review 8.  Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Authors:  Cornelis J Lips; Koen M Dreijerink; Jo W Höppener
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.